Green Thumb IndustriesGTBIF 85 Days Payable is 13.01 as of Mar. 2026, which is 16% below its 10-year median of 15.50. GuruFocus rates GTBIF with a GF Score™ of 85/100 and a GF Value™ of $8.76 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 922 Drug Manufacturers companies, Green Thumb Industries ranks worse than 97.61% on this metric.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Green Thumb Industries's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Green Thumb Industries Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Green Thumb Industries's Days Payable distribution charts can be found below:
* The bar in red indicates where Green Thumb Industries's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Green Thumb Industries's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Green Thumb Industries (GTBIF) has a Days Payable of 13.01 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Green Thumb Industries and its competitors. This is 16% below median its historical median of 15.50. Over the past decade, Green Thumb Industries' Days Payable has ranged from 11.27 to 21.33. According to the industry distribution chart, Green Thumb Industries ranks #900 out of 922 companies in the Drug Manufacturers industry, placing it in the top 97.6%.
Is Green Thumb Industries' Days Payable too high?
Green Thumb Industries' current Days Payable of 13.01 is 16% below median its 10-year median of 15.50. Over the past 10 years, this metric has ranged from a low of 11.27 to a high of 21.33. The Drug Manufacturers industry median Days Payable is 90.84. Green Thumb Industries' value of 13.01 is 85.7% below this industry median. Based on the distribution chart, Green Thumb Industries ranks #900 out of 922 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Green Thumb Industries has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Green Thumb Industries' Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Green Thumb Industries ranks #900 out of 922 companies for Days Payable. This places Green Thumb Industries in the lower half of its industry. The industry median Days Payable is 90.84. Green Thumb Industries' value of 13.01 is 85.7% below this benchmark. Historically, Green Thumb Industries' own Days Payable has ranged from 11.27 to 21.33 over the past decade. While the company's 10-year median is 15.50 vs. the industry median of 90.84, Green Thumb Industries has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Green Thumb Industries's current Days Payable of 13.01 is 85.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Green Thumb Industries and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Green Thumb Industries's current Days Payable is 13.01, which is 16% below median its own 10-year median of 15.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Green Thumb Industries stock overvalued right now?
Based on GuruFocus' analysis, Green Thumb Industries (GTBIF) is currently considered Modestly Undervalued. The stock's GF Value™ is $8.76, compared to a current price of $7.60 — trading 13.2% below its estimated fair value. The current Days Payable is 13.01, which is 16% below median its 10-year median of 15.50 and 85.7% below the Drug Manufacturers industry median of 90.84. Green Thumb Industries' overall GF Score™ is 85/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Green Thumb Industries (GTBIF), the current Days Payable is 13.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Green Thumb Industries (GTBIF) Overvalued in 2026?
Based on GuruFocus' analysis, Green Thumb Industries stock appears to be undervalued.
The current stock price of $7.60 is trading 13.2% below its estimated GF Value™ of $8.76.
GuruFocus considers Green Thumb Industries to be Modestly Undervalued.
Key valuation signals for GTBIF:
Days Payable: 13.01 (16% below median its 10-year median of 15.50)
GF Value™: $8.76 vs. price of $7.60 (13.2% below fair value)
Industry Position: 85.7% below the Drug Manufacturers median (#900 of 922)
No single metric tells the full story. See the GTBIF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates more than 100 cannabis stores under the brand Rise. GTI is focusing its expansion on limited-license states with large populations, and it does not currently export into the global medical market due to the USA federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, Incredibles, and RYTHM.
85GF Score
Get the complete analysis for GTBIF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GTBIF has been successfully added to your 
